Results

Total Results: 222 records

Showing results for "sedation".

1. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
   December 01, 2014 - using Sedasys to benzodiazepine/opiate-mediated sedation. … Endoscopist/nurse teams administered both sedation methods. … of propofol for sedation during endoscopies, experts also commented. … compared with benzodiazepine/opioid sedation. … An assessment of computer-assisted personalized sedation: a sedation delivery system to administer

2. App-F2-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
   May 29, 2025 - Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Nausea: n Nausea: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Dry Mouth: n Dry Mouth: N N Randomized Dizziness: … : Specific AE Sedation: n Sedation: N N Randomized Dizziness: n Dizziness: N N Randomized Weight Gain … Randomized Dizziness: n Dizziness: N N Randomized Peripheral Edema: n Peripheral Edema: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Weight Gain: n Weight Gain: N N Randomized Khasbage

3. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
   June 01, 2014 - delivered using Sedasys to benzodiazepine/opiate-mediated sedation. … sedation during routine endoscopy procedures. … Endoscopist/nurse teams administered both sedation methods. … compared with benzodiazepine/opioid sedation. … An assessment of computer-assisted personalized sedation: a sedation delivery system to administer

4. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
   May 29, 2025 - Specific AE Cognitive Effects: n Cognitive Effects: N N Randomized Dry Mouth: n Dry Mouth: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Dizziness: n Dizziness: N N Randomized Weight Gain … Randomized Dizziness: n Dizziness: N N Randomized Peripheral Edema: n Peripheral Edema: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Weight Gain: n Weight Gain: N N Randomized Lee, 2020

5. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
   May 29, 2025 - Specific AE Cognitive Effects: n Cognitive Effects: N N Randomized Dry Mouth: n Dry Mouth: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Dizziness: n Dizziness: N N Randomized Weight Gain … Randomized Dizziness: n Dizziness: N N Randomized Peripheral Edema: n Peripheral Edema: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Weight Gain: n Weight Gain: N N Randomized Khasbage

6. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
   October 01, 2021 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … associated with moderate improvement in pain severity, no effect on overall function and increased risk of sedation … [SOE]a Dizziness Effect Size (N Studies) [SOE]a Nausea Effect Size (N Studies) [SOE]a Sedation … the results with recent systematic reviews that used the same methodology, suggests that the risk of sedation … were found with comparable THC to CBD ratio oral sprays, with large increased risk of dizziness and sedation

7. Cer-243-Prehospital-Airway-Management-Appendix-F-1 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
   January 01, 2016 - (etomidate-only) 24 Harms Aspiration ITT Technique/Device ETI: RSI vs. sedation-facilitated No cases … No medication Sedation-facilitated vs. … No medication Sedation-facilitated vs. … Sedation-facilitated RSI vs. … Sedation-facilitated RSI vs.

8. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
   January 01, 2018 - SAE SAE Cognitive Effects Cognitive Effects Cognitive Effects Cognitive Effects Nausea Nausea Nausea Sedation … Sedation Sedation Sedation Serotonin Syndrome Serotonin Syndrome Serotonin Syndrome Serotonin Syndrome … , 2009 Fair LBP SNRI Duloxetine 120 mg/d 13 Short 27 112 3 112 Confusional state 0 112 NR 14 112 NR Sedation … Sedation Sedation Sedation Weight Gain Weight Gain Weight Gain Author, Year Quality Pain Population … Sedation Sedation Sedation Author, Year Quality Pain Population Drug Class Drug Assessment Time (wk

9. Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
   January 01, 2023 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … high-THC to CBD) may be associated with small improvement in pain severity, but with increased risk of sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … placebo, these interventions resulted in greater risk of common adverse events (dizziness, nausea, sedation

10. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
    February 01, 2008 - Potentiate GABA receptor function Absence Atypical Absence Myoclonic Neurological: ataxia, sedation … and increase GABA availability Partial Lennox- Gastaut Neurological: insomnia, dizziness, sedation … Tonic- Clonic Atypical Absence Myoclonic Lennox- Gastaut Neurological: dizziness, diplopia, sedation … Yes Phenobarbital Potentiate GABA receptor function Partial Tonic- Clonic Neurological: sedation … No Tiagabine Increase GABA availability Partial Tonic- Clonic Neurological: confusion, sedation

11. TND-0775-150722 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0775-150722.pdf
    May 12, 2015 - medications, such as Parkinsonism, akathisia, dystonia, and tardive dyskinesia), prolactin elevation, sedation … medication (e.g., diabetes mellitus, extrapyramidal symptoms / tardive dyskinesia, prolactin elevation, sedation

12. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
    January 01, 2022 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … high-THC to CBD) may be associated with moderate improvement in pain severity, but with increased risk of sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … the results with recent systematic reviews that used the same methodology, suggests that the risk of sedation … placebo, these interventions resulted in greater risk of common adverse events (dizziness, nausea, sedation

13. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2025 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-executive-sum.pdf
    January 01, 2025 - There may be a large increased risk of dizziness and sedation (SOE: low) and a moderate increased risk … associated with small improvement in pain severity (SOE: low), but with increased risk of WAEs (SOE: low), sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … placebo, these interventions resulted in greater risk of common adverse events (dizziness, nausea, sedation

14. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    May 29, 2025 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

15. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    May 29, 2025 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

16. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
    January 01, 2024 - There may be a large increased risk of dizziness and sedation (SOE: low) and a moderate increased risk … associated with small improvement in pain severity (SOE: low), but with increased risk of WAEs (SOE: low), sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … placebo, these interventions resulted in greater risk of common adverse events (dizziness, nausea, sedation

17. Evidence Summary: Comparative Effectiveness Review No. 236 Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
    April 01, 2021 - • Brexanolone probably improves depressive symptoms; it may increase the risk of sedation or somnolence … in the third trimester or within 4 weeks of birth, brexanolone may be associated with the risk of sedation

18. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Consistent with prior evidence, gabapentin was associated with increased risk of dizziness, sedation … in cognitive AEs • SOE: Low. based on 8 RCTs Large increase in dizziness, peripheral edema, sedation … (n=366) found increased risk of dizziness.6,7,9 1 RCT (n=306) found increased risk of SAEs, sedation … THC/CBD associated with large increase in WAEs, dizziness, nausea, but no increase in SAEs or sedation … SOE for large increase in risk for cognitive effects, moderate SOE for large increase in risk for sedation

19. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - Other common side effects are dry mouth and sedation. … Patient-, parent- or care impressions symptoms side effects provider-reported outcomes Depression Tics Sedation … difference. sexual AE (1 RCT, 1 PCS) Haloperidol vs. risperidone Low No significant difference. (2 RCTs) Sedation … SGA (continued) Sedation Clozapine vs. olanzapine Low No significant difference. (1 RCT, 1 PCS, 1 RCS … Sedation Aripiprazole vs. placebo (4 RCTs) Low Significant effect in favor of placebo (RR = 2.7, 95%

20. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - from Surveillance Report 2 found increased risk of WAEs and nonsignificantly increased risk of sedation … 95% CI, 1.88 to 5.34, I2=0%) • Dizziness (28 RCTs): RR 2.85 (95% CI, 2.43 to 3.34, I2=36%) • Sedation … THC/CBD associated with large increase in WAEs, dizziness, nausea, but no increase in SAEs or sedation … 4.48 (95% CI, 2.77 to 7.22, I2=0%) • Nausea (2 RCTs): RR 2.11 (95% CI, 1.20 to 3.72, I2=0%) • Sedation … Gabapentin/pregabalin harms, sedation Abbreviations: CI=confidence interval; CPP=chronic pelvic pain